Skip to main content

Table 1 Clinicopathological characteristics

From: Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution series

Variable All (n = 138) Low (n = 59) High (n = 79) P
Gender     0.014
 Male 105 51 54  
 Female 33 8 25  
Age(years)     0.004
 < 65 80 26 54  
 ≥ 65 58 33 25  
BMI(kg/m2)     0.007
 < 25 115 55 60  
 ≥ 25 23 4 19  
ASA     0.664
 1 69 28 41  
 2 54 23 31  
 3 15 8 7  
Comorbidities     0.471
 No 40 19 21  
 Yes 98 40 58  
Tumor diameter(mm)     0.037
 < 50 68 23 45  
 ≥ 50 70 36 34  
Tumor location     0.783
 Upper 63 26 37  
 Middle 27 12 15  
 Lower 33 16 17  
 Mix 15 5 10  
T stage     0.471
 T1 + T2 77 35 42  
 T3 + T4 61 24 37  
N stage     0.181
 N0 46 16 30  
 N1 92 43 49  
Surgical method     0.103
 Open 43 14 29  
 Laparoscopic 95 45 50  
Gastrectomy extent     0.67
 Total 101 45 56  
 Distal 33 13 20  
 Proximal 4 1 3  
Pathological type     0.318
 NET 12 3 9  
 NEC 52 21 31  
 MANEC 74 35 39  
Ki-67 positive index (%)     0.439
 < 60 59 23 36  
 ≥ 60 79 36 43  
Complications     0.984
 No 82 35 47  
 Yes 56 24 32  
Adjuvant chemotherapy     0.193
 No 66 32 34  
 Yes 72 27 45  
  1. SMI Skeletal muscle index, BMI Body mass index, ASA American Society of Anesthesiologists, NET Neuroendocrine tumor, NEC Neuroendocrine carcinoma, MANEC Mixed adenoneuroendocrine carcinoma